GENE ONLINE|News &
Opinion
Blog

Novo Nordisk
Partnerships PfizerFlagship Pioneering
Pfizer Partners with Renowned Life Sciences VC to Build Pipeline Projected to be Worth $7 Billion
2023-07-20
Partnerships Type 1 DiabetesCell Therapy
Novo Nordisk and Aspect Team Up to Develop Bioprinting-Based Diabetes Treatment
2023-04-13
Special Insulin
Novo Nordisk Announces Major Insulin Price Cut by Up to 75%, Following in the Footsteps of Eli Lilly
2023-03-15
Special biopharmam&a
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
M&A Novo Nordisk
Novo Nordisk Finally Finalizes their Billion Dollar Acquisition of Forma Therapeutics
2022-10-14
Licensing Novo Nordisk
Novo Nordisk Places $700 Million Bet on Ventus’ NLRP3 Inhibitor Program
2022-09-30
Trials & Approvals Novo Nordisk
Novo Nordisk’s Once-Weekly Insulin Snags Another Victory
2022-09-22
M&A Novo Nordisk
Novo Nordisk Seals the Deal On A $1.1 Billion Acquisition of Forma Therapeutics
2022-09-01
Funding Financial TimesNovo Nordisk
Novo Nordisk Increased Sales by 25% in H1 2022
2022-08-03
Trials & Approvals Diabetes
Novo Nordisk’s Type 2 Diabetes Drug Gets Greenlight in Korea
2022-05-04
M&A Best of 2021
GeneOnline’s Top 10 M&As of 2021
2022-01-11
M&A RNA Therapeutics
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
Trials & Approvals Obesity
Novo Nordisk’s Weight Loss Drug Shines in Phase 3 Trial
2021-11-07
Trials & Approvals
Long Standing Rivalry in Diabetes Market Intensifies as Eli Lilly’s Drug Outshines Novo’s in Head to Head Trial
2021-03-05
Trials & Approvals Obesity
Study Shows New Diabetes Drug Induces Remarkable Weight Loss in Obese Patients
2021-02-15
1 2 3
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top